Interestingly, a loss of TGF-β receptor type II was observed in epithelial but not in stromal cells during PCa development, and this could explain the direct antagonistic role of TGF-β against cancer cells during progression [93,94]. The gene discussed is TGFB1; the disease is posterior cortical atrophy.